Dalrada Financial Corp Acquires Pacific Stem Cells, International Health Group and Stake in CHP Industrial Solutions

Dalrada Health (Sòlas) Acquires Remedi Med Spas

April 12, 2022

Healthcare Services

Dalrada Corporation's Dalrada Health division, operating under the Sòlas Rejuvenation + Wellness group, acquired Remedi Med Spas and its two Southern California locations in Coronado and Mission Hills from Dr. Rakhesh Guttikonda. The acquisition adds two clinics and staff to the North San Diego–based Sòlas platform as part of its regional expansion of wellness and aesthetic services.

Dalrada Corporation Acquires Watson Rx Solutions, Inc.

June 8, 2022

Healthcare Services

Dalrada Corporation (OTCQB: DFCO) has acquired Watson Rx Solutions, Inc., a 10-year-old pharmacy, to expand its Dalrada Health subsidiary and build an end-to-end healthcare offering that includes pharmacy services. The acquisition is intended to enhance Dalrada's ability to provide prescription processing alongside its clinics, telemedicine, testing facilities and other healthcare technologies.

Johnson & Johnson Acquires Halda Therapeutics for $3.05 Billion

December 29, 2025

Biotechnology

Johnson & Johnson completed the acquisition of Halda Therapeutics OpCo, Inc. for $3.05 billion in cash, adding Halda's RIPTAC platform and clinical-stage prostate cancer candidate HLD-0915 to its oncology portfolio. The deal brings several earlier-stage RIPTAC-based programs for other solid tumors and positions J&J to advance oral targeted therapies that may overcome treatment resistance.

QHP Capital Acquires Applied StemCell

October 9, 2023

Biotechnology

QHP Capital has acquired Applied StemCell, a Milpitas, California–based cell and gene therapy CRO/CDMO that provides iPSC and TARGATT gene‑editing platforms for biopharma and research clients. QHP said the acquisition will provide strategic capital and operating support to accelerate ASC's commercial expansion and scale its manufacturing and service capabilities for the cell and gene therapy market.

Columbia Pacific Capital Partners Invests in Panacea Healthcare Solutions; Panacea Acquires Holliday & Associates and First Healthcare Compliance

August 26, 2022

Healthcare Services

Columbia Pacific Capital Partners (CPCP) has partnered with Panacea Healthcare Solutions to support Panacea's next stage of growth. With CPCP's investment, Panacea has simultaneously acquired Holliday & Associates and First Healthcare Compliance to expand its chargemaster, pricing transparency, compliance, and mid-revenue cycle software and services for hospitals, health systems, and physician practices.

TerrAscend Corp. Acquires Peninsula Alternative Health (Derby 1, LLC) for US$22.1M

June 8, 2023

Retail

TerrAscend Corp. entered into a definitive agreement to acquire Derby 1, LLC (d/b/a Peninsula Alternative Health), an 8,500 sq ft medical cannabis dispensary in Salisbury, Maryland, for total consideration of US$22.1 million, including US$1.5 million in cash. The acquisition, expected to be immediately accretive to EBITDA and cashflow, expands TerrAscend's retail footprint to 35 dispensaries and positions the company ahead of Maryland's July 1, 2023 adult-use launch.